📊 EBRCZ Key Takeaways
Is EBRCZ a Good Investment? Thesis Analysis
EBR Systems is in severe financial distress with collapsing revenues (-49.2% YoY), massive operating losses (-$46.1M), and deeply negative cash flow (-$53.2M operating, -$56.9M free cash flow). Despite adequate liquidity ratios, the company is burning cash rapidly with only $5.8M in cash against $41.8M in long-term debt, indicating insolvency risk within 12 months absent dramatic operational turnaround or capital infusion.
Why Buy EBRCZ? Key Strengths
- Positive gross margin of 30.3% indicates product-level economics are viable
- Current ratio of 5.20x provides near-term liquidity buffer for operations
- Only 1 insider Form 4 filing in 90 days suggests minimal opportunistic selling
EBRCZ Investment Risks to Consider
- Revenue collapse of 49.2% YoY indicates severe demand destruction or market rejection
- Operating cash burn of $53.2M with only $5.8M cash on hand creates imminent liquidity crisis
- Long-term debt of $41.8M versus equity of $25.6M with negative interest coverage (-8.2x) signals debt default risk
- Net losses of $48.8M and operating losses of $46.1M show unsustainable business model
- Negative free cash flow of $56.9M indicates company cannot self-fund operations
Key Metrics to Watch
- Monthly operating cash burn rate and cash runway to depletion
- Revenue stabilization or recovery trajectory in next two quarters
- Debt covenant compliance status and refinancing availability
- Capital raising activities including equity dilution or debt restructuring
EBRCZ Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 5.20x current ratio provides a solid financial cushion.
EBRCZ Profitability Ratios
EBRCZ vs Healthcare Sector
How EBR Systems, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is EBRCZ Overvalued or Undervalued?
Based on fundamental analysis, EBR Systems, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
EBRCZ Balance Sheet & Liquidity
EBRCZ 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: EBR Systems, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.13 indicates the company is currently unprofitable.
EBRCZ Growth Metrics (YoY)
EBRCZ Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $512.1K | -$10.1M | $-0.03 |
| Q2 2025 | $169.7K | -$11.5M | $-0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
EBRCZ Capital Allocation
EBRCZ SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for EBR Systems, Inc. (CIK: 0001347123)
📋 Recent SEC Filings
❓ Frequently Asked Questions about EBRCZ
What is the AI rating for EBRCZ?
EBR Systems, Inc. (EBRCZ) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are EBRCZ's key strengths?
Claude: Positive gross margin of 30.3% indicates product-level economics are viable. Current ratio of 5.20x provides near-term liquidity buffer for operations.
What are the risks of investing in EBRCZ?
Claude: Revenue collapse of 49.2% YoY indicates severe demand destruction or market rejection. Operating cash burn of $53.2M with only $5.8M cash on hand creates imminent liquidity crisis.
What is EBRCZ's revenue and growth?
EBR Systems, Inc. reported revenue of $1.6M.
Does EBRCZ pay dividends?
EBR Systems, Inc. does not currently pay dividends.
Where can I find EBRCZ SEC filings?
Official SEC filings for EBR Systems, Inc. (CIK: 0001347123) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is EBRCZ's EPS?
EBR Systems, Inc. has a diluted EPS of $-0.12.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is EBRCZ a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, EBR Systems, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is EBRCZ stock overvalued or undervalued?
Valuation metrics for EBRCZ: ROE of -190.6% (sector avg: 15%), net margin of -3,015.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy EBRCZ stock in 2026?
Our dual AI analysis gives EBR Systems, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is EBRCZ's free cash flow?
EBR Systems, Inc.'s operating cash flow is $-53.2M, with capital expenditures of $3.7M. FCF margin is -3,517.3%.
How does EBRCZ compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -3,015.3% (avg: 12%), ROE -190.6% (avg: 15%), current ratio 5.20 (avg: 2).